Becky Ancira Robertson
banner
ancirabecky.bsky.social
Becky Ancira Robertson
@ancirabecky.bsky.social
Survivor. Proud mother. Teacher. Activist. Trying to make a difference.
#PatientAdvocate #longcovidawareness #LCDC #March15 #ValueCognition #WHN

Interview with @theWHN :
https://youtu.be/YUgcqJ-m7C0
Reposted by Becky Ancira Robertson
❤️ Australia! #covid #LongCovid

'Check out these graphics posted this week by the Heart Foundation of Australia - not too mild, is it?'

x.com/chantz_y/sta...
November 26, 2025 at 9:25 PM
Reposted by Becky Ancira Robertson
HOLY CRAP.
Read this ... the NHS has inadvertently tracked the effects of long covid (and deliberately mucked up the data recording criteria to hide covid associated deaths).
🚨🧵 by @1goodtern.bsky.social on Twitter:

"... I've just stumbled across the official NHS coding guidance for U07.3 - 'Personal history of Covid-19' - and it left me on the floor.
🚨When paired with the data on the number of times it is currently used, it is a..."

threadreaderapp.com/thread/19937...
November 26, 2025 at 11:09 PM
Reposted by Becky Ancira Robertson
#SFU Health Sciences investigators surveyed Canadian #LongCOVID patients, and found that many participants consider #VirtualCare "lifesaving and essential," while also noting that their #PrimaryCare providers had little-to-no awareness of the condition.

bit.ly/3JXo5HZ

#SFUFHS #CovidResearch
National survey finds virtual health ‘essential’ for Long COVID support: SFU report
Researchers at the SFU Faculty of Health Sciences surveyed Canadian Long COVID patients, and found that many people with the condition consider virtual care "lifesaving and essential," while also noti...
www.sfu.ca
November 26, 2025 at 11:18 PM
Reposted by Becky Ancira Robertson
Linköping University researchers showed that amyloid fibrils from the SARS-CoV-2 spike protein can form abnormal blood clots.

One fragment, Spike685, made clots that resisted breakdown, offering a possible mechanism for long COVID symptoms.

pubs.acs.org/doi/10.1021/...
SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis
Long COVID, or postacute sequelae of COVID-19 from SARS-CoV-2 infection, is a persistent debilitating disease affecting multiple systems and organs. Long COVID pathophysiology is a complex and not fully established process. One prevailing theory is that the formation of fibrin amyloid microclots (fibrinaloids), due to SARS-CoV-2 infection, can induce persistent inflammation and capillary blockage. An association between the amyloidogenic Spike protein of SARS-CoV-2 and impaired fibrinolysis was made when it was observed that fibrin clots formed in the presence of a mixture of amyloid fibrils from the spike protein mediated resistance to plasmin lysis. Here, we use purified components from the coagulation cascade to investigate the molecular processes of impaired fibrinolysis using seven amyloidogenic SARS-COV-2 Spike peptides. Five of seven Spike amyloid fibrils appeared not to substantially interfere with the fibrinogen–fibrin–fibrinolysis process in vitro, while two spike fibrils were active in different ways. Spike601 amyloid fibrils (sequence 601–620) impaired thrombin-mediated fibrin formation by binding and sequestering fibrinogen but did not affect fibrinolysis. On the contrary, fibrin clots formed in the presence of Spike685 amyloid fibrils (sequence 685–701) exhibited a marked resistance to plasmin-mediated fibrinolysis. We conclude that Spike685 amyloid fibrils can induce dense fibrin clot networks as well as incorporate fibrin into aggregated structures that resist fibrinolysis. Our study proposes a molecular mechanism for how the Spike protein of SARS-CoV-2 could contribute to the formation of fibrinolysis-resistant microclots observed in long COVID.
pubs.acs.org
November 26, 2025 at 11:50 PM
Reposted by Becky Ancira Robertson
"Mechanistically, T cells, particularly Th17 cells, rather than monocytes, were identified as the key drivers of sustained inflammation beyond one year. Selective inhibition of pathogenic Th17 subsets might be a potential therapy for long COVID."

Big if true.
November 27, 2025 at 12:41 AM
Reposted by Becky Ancira Robertson
Celiac Plexus Block Brings Major Relief for Long COVID Gut Issues

www.thailandmedical.news/news/celiac-...
Celiac Plexus Block Brings Major Relief for Long COVID Gut Issues - Thailand Medical News
www.thailandmedical.news
November 25, 2025 at 6:25 AM
Reposted by Becky Ancira Robertson
Reposted by Becky Ancira Robertson
It shouldn't take this long to get diagnosed. For anyone. If doctors would read the literature they'd know that it is not necessary to rule out every other malady known to man to Dx long COVID, especially when all of the patient's symptoms fit with long COVID, and they have no symptoms that do not.
November 24, 2025 at 4:04 AM
Reposted by Becky Ancira Robertson
Costs of #LongCovid "are estimated at an average annual burden of $1 trillion globally"

www.nature.com/articles/s41...
www.nature.com
November 23, 2025 at 10:57 PM
Reposted by Becky Ancira Robertson
"No pharmacological or behavioral therapy has yet shown clear benefit for cognitive Long COVID."

www.forbes.com/sites/gregli...
Long COVID’s Shadow Lingers
Long COVID has exposed both the limits of current clinical science and the challenges of pharmaceutical strategy
www.forbes.com
November 24, 2025 at 3:17 AM
Reposted by Becky Ancira Robertson
Covid kills 10 times more people than seasonal flu (influenza)

bsky.app/profile/mori...
INFLUENZA VS COVID-19 DEATHS IN CANADA
This thread is also available on the C-19 website, starting on page 8, for easier reading.
Risk Scenario Estimator Based on Canadian Forecast
https://t.co/sl9i5g5QKa
#CovidIsAirborne #CovidIsntOver #MaskUp #YallMasking #CleanTheAir
November 22, 2025 at 12:25 AM
Reposted by Becky Ancira Robertson
Join the LC-REVITALIZE Long COVID Study!

Adults 18–65 with persistent Long COVID can participate in San Diego ([email protected]
| 619-324-8677) or 7 other global sites. 6 months, 8 visits, FDA-approved drugs tested. Reimbursement provided.

clinicaltrials.gov/study/NCT069...
November 21, 2025 at 8:50 PM